Inventor
Leonie Alten
Inventor
Tuebingen, DE
Overview
Patents· 21 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes26%
C07KPeptides26%
C12NMicroorganisms or enzymes22%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations19%
G01NInvestigating or analysing materials by determining their chemical or physical properties8%
PatentTitleYear
11,111,286T cell receptors and immune therapy using the same against PRAME positive cancers202111,111,294T cell receptors and immune therapy using the same202111,072,645T cell receptors with improved pairing202110,889,645Engineered T cell receptors and immune therapy using the same202110,889,629Transfected T-cells and T-cell receptors for use in immunotherapy against cancers202110,874,731T cell receptors and immune therapy using the same202010,800,845T cell receptors and immune therapy using the same202010,800,832T cell receptors and immune therapy using the same against prame positive cancers202010,759,842T cell receptors and immune therapy using the same against prame positive cancers202010,723,796T cell receptors and immune therapy using the same202010,725,044T cell receptors and immune therapy using the same202010,702,609T cell receptors and immune therapy using the same202010,626,160Transfected T-cells and T-cell receptors for use in immunotherapy against cancers202010,618,956Engineered T cell receptors and immune therapy using the same202010,596,242Transfected T-cells and T-cell receptors for use in immunotherapy against cancers202010,590,194T cell receptors and immune therapy using the same202010,550,182T cell receptors and immune therapy using the same202010,538,573Transfected T-cells and T-cell receptors for use in immunotherapy against cancers202010,537,624Transfected T-cells and T-cell receptors for use in immunotherapy against cancers202010,527,623T cell receptors and immune therapy using the same202010,526,407T cell receptors and immune therapy using the same2020Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2020–2021Patents assigned to IMMATICS BIOTECHNOLOGIES GMBH (20)· patent assignee history
2020–2021Based in Tuebingen, DE· patent location history
2020–2021Based in Tubingen, DE· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| IMMATICS BIOTECHNOLOGIES GMBH | 20 | 2020–2021 |
Locations
| Location | Patents | Span |
|---|---|---|
| Tuebingen, DE | 14 | 2020–2021 |
| Tubingen, DE | 7 | 2020–2021 |